questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Chimiokines
Chimiokines CX3C
Chimiokines CX3C : Questions médicales fréquentes
Termes MeSH sélectionnés :
Reproducibility of Results
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chimiokines CX3C : Questions médicales les plus fréquentes",
"headline": "Chimiokines CX3C : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chimiokines CX3C : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chimiokines CX3C"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chimiokines",
"url": "https://questionsmedicales.fr/mesh/D018925",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines",
"code": {
"@type": "MedicalCode",
"code": "D018925",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimiokine CX3CL1",
"alternateName": "Chemokine CX3CL1",
"url": "https://questionsmedicales.fr/mesh/D054428",
"about": {
"@type": "MedicalCondition",
"name": "Chimiokine CX3CL1",
"code": {
"@type": "MedicalCode",
"code": "D054428",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.200.130.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Chimiokines CX3C",
"alternateName": "Chemokines, CX3C",
"code": {
"@type": "MedicalCode",
"code": "D020523",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Noha Mousaad Elemam",
"url": "https://questionsmedicales.fr/author/Noha%20Mousaad%20Elemam",
"affiliation": {
"@type": "Organization",
"name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "Azzam A Maghazachi",
"url": "https://questionsmedicales.fr/author/Azzam%20A%20Maghazachi",
"affiliation": {
"@type": "Organization",
"name": "College of Medicine and Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates."
}
},
{
"@type": "Person",
"name": "J Robert Lane",
"url": "https://questionsmedicales.fr/author/J%20Robert%20Lane",
"affiliation": {
"@type": "Organization",
"name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom."
}
},
{
"@type": "Person",
"name": "Meritxell Canals",
"url": "https://questionsmedicales.fr/author/Meritxell%20Canals",
"affiliation": {
"@type": "Organization",
"name": "Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom."
}
},
{
"@type": "Person",
"name": "Martin J Stone",
"url": "https://questionsmedicales.fr/author/Martin%20J%20Stone",
"affiliation": {
"@type": "Organization",
"name": "Monash Biomedicine Discovery Institute, and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Advice for improving the reproducibility of data extraction in meta-analysis.",
"datePublished": "2023-08-11",
"url": "https://questionsmedicales.fr/article/37571802",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jrsm.1663"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducibility of pulmonary function tests in patients with systemic sclerosis.",
"datePublished": "2023-11-03",
"url": "https://questionsmedicales.fr/article/37923803",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-45881-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducibility of Bartoníček and Haraguchi classifications of the posterior malleolus fractures.",
"datePublished": "2023-03-11",
"url": "https://questionsmedicales.fr/article/36905426",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00402-023-04823-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Reproducibility of cerebral perfusion measurements using BOLD delay.",
"datePublished": "2023-02-25",
"url": "https://questionsmedicales.fr/article/36840928",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/hbm.26244"
}
},
{
"@type": "ScholarlyArticle",
"name": "Test-retest reproducibility of human brain multi-slice",
"datePublished": "2022-09-21",
"url": "https://questionsmedicales.fr/article/36128885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mrm.29423"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chimiokines",
"item": "https://questionsmedicales.fr/mesh/D018925"
},
{
"@type": "ListItem",
"position": 6,
"name": "Chimiokines CX3C",
"item": "https://questionsmedicales.fr/mesh/D020523"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chimiokines CX3C - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chimiokines CX3C",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chimiokines CX3C",
"description": "Comment diagnostiquer une dysrégulation des chimiokines CX3C ?\nQuels marqueurs sont associés aux chimiokines CX3C ?\nLes chimiokines CX3C sont-elles mesurables dans le liquide céphalorachidien ?\nQuel rôle jouent les chimiokines CX3C dans les maladies auto-immunes ?\nPeut-on détecter les chimiokines CX3C dans les biopsies ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Reproducibility+of+Results&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chimiokines CX3C",
"description": "Quels symptômes sont liés à une surproduction de chimiokines CX3C ?\nLes chimiokines CX3C peuvent-elles causer des douleurs articulaires ?\nComment les chimiokines CX3C affectent-elles le système respiratoire ?\nLes chimiokines CX3C sont-elles impliquées dans les allergies ?\nQuels signes cliniques indiquent une activation des chimiokines CX3C ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Reproducibility+of+Results&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chimiokines CX3C",
"description": "Comment prévenir les maladies liées aux chimiokines CX3C ?\nLes vaccins influencent-ils les chimiokines CX3C ?\nY a-t-il des mesures préventives pour les maladies inflammatoires ?\nL'hygiène joue-t-elle un rôle dans la régulation des chimiokines CX3C ?\nLes compléments alimentaires peuvent-ils aider à réguler les chimiokines ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Reproducibility+of+Results&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chimiokines CX3C",
"description": "Quels traitements ciblent les chimiokines CX3C ?\nLes anti-inflammatoires affectent-ils les chimiokines CX3C ?\nComment les corticostéroïdes influencent-ils les chimiokines CX3C ?\nY a-t-il des traitements expérimentaux pour les chimiokines CX3C ?\nLes thérapies géniques peuvent-elles cibler les chimiokines CX3C ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Reproducibility+of+Results&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chimiokines CX3C",
"description": "Quelles complications peuvent survenir avec une surproduction de chimiokines CX3C ?\nLes chimiokines CX3C sont-elles liées à des cancers ?\nComment les chimiokines CX3C affectent-elles la santé cardiovasculaire ?\nLes complications neurologiques sont-elles possibles avec les chimiokines CX3C ?\nLes chimiokines CX3C peuvent-elles aggraver des infections ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Reproducibility+of+Results&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chimiokines CX3C",
"description": "Quels facteurs de risque sont associés aux chimiokines CX3C ?\nL'âge influence-t-il les niveaux de chimiokines CX3C ?\nLes infections antérieures augmentent-elles le risque lié aux chimiokines CX3C ?\nLe stress psychologique affecte-t-il les chimiokines CX3C ?\nLes habitudes alimentaires influencent-elles les chimiokines CX3C ?",
"url": "https://questionsmedicales.fr/mesh/D020523?mesh_terms=Reproducibility+of+Results&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des chimiokines CX3C ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines peuvent aider à évaluer les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont associés aux chimiokines CX3C ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de CX3CL1 et de CX3CR1 sont souvent mesurés comme marqueurs d'inflammation."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C sont-elles mesurables dans le liquide céphalorachidien ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chimiokines CX3C peuvent être détectées dans le liquide céphalorachidien lors de certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les chimiokines CX3C dans les maladies auto-immunes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont souvent impliquées dans l'infiltration des cellules immunitaires dans les tissus affectés."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les chimiokines CX3C dans les biopsies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent révéler des niveaux élevés de chimiokines CX3C dans les tissus enflammés."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une surproduction de chimiokines CX3C ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent inflammation, douleur, et dysfonction immunitaire dans diverses maladies."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C peuvent-elles causer des douleurs articulaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surproduction peut contribuer à l'inflammation et à la douleur dans les articulations."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CX3C affectent-elles le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer une inflammation des voies respiratoires, entraînant des symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C sont-elles impliquées dans les allergies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent jouer un rôle dans la réponse allergique en attirant les cellules immunitaires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une activation des chimiokines CX3C ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur au site d'inflammation sont des signes cliniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées aux chimiokines CX3C ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, peut aider."
}
},
{
"@type": "Question",
"name": "Les vaccins influencent-ils les chimiokines CX3C ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins peuvent moduler la réponse des chimiokines CX3C pour une meilleure immunité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les maladies inflammatoires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac et gérer le stress peuvent réduire le risque de maladies inflammatoires."
}
},
{
"@type": "Question",
"name": "L'hygiène joue-t-elle un rôle dans la régulation des chimiokines CX3C ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène peut réduire les infections et, par conséquent, l'activation des chimiokines."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires peuvent-ils aider à réguler les chimiokines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments, comme les oméga-3, peuvent moduler l'activité des chimiokines CX3C."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les chimiokines CX3C ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies biologiques et des inhibiteurs de chimiokines sont utilisés pour moduler leur activité."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires affectent-ils les chimiokines CX3C ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anti-inflammatoires peuvent réduire la production de chimiokines CX3C dans l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment les corticostéroïdes influencent-ils les chimiokines CX3C ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes diminuent l'expression des chimiokines CX3C, réduisant ainsi l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour les chimiokines CX3C ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des essais cliniques explorent des inhibiteurs spécifiques des chimiokines CX3C."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques peuvent-elles cibler les chimiokines CX3C ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches de thérapie génique sont en développement pour moduler l'expression des chimiokines."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une surproduction de chimiokines CX3C ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des maladies auto-immunes, des allergies sévères et des infections chroniques."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C sont-elles liées à des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation des chimiokines CX3C peut être associée à certains types de cancers."
}
},
{
"@type": "Question",
"name": "Comment les chimiokines CX3C affectent-elles la santé cardiovasculaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent contribuer à l'inflammation vasculaire, augmentant le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles avec les chimiokines CX3C ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés peuvent être impliqués dans des troubles neurologiques comme la sclérose en plaques."
}
},
{
"@type": "Question",
"name": "Les chimiokines CX3C peuvent-elles aggraver des infections ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une réponse inflammatoire excessive peut aggraver les infections et retarder la guérison."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux chimiokines CX3C ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et le stress chronique sont des facteurs de risque connus."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de chimiokines CX3C ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut augmenter les niveaux de chimiokines CX3C, favorisant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les infections antérieures augmentent-elles le risque lié aux chimiokines CX3C ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections passées peuvent sensibiliser le système immunitaire et augmenter les niveaux de chimiokines."
}
},
{
"@type": "Question",
"name": "Le stress psychologique affecte-t-il les chimiokines CX3C ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter la production de chimiokines CX3C, exacerbant l'inflammation."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les chimiokines CX3C ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses saturées peut augmenter les niveaux de chimiokines CX3C."
}
}
]
}
]
}
Extracting data from studies is the norm in meta-analyses, enabling researchers to generate effect sizes when raw data are otherwise not available. While there has been a general push for increased re...
Systemic sclerosis (SSc) is a rare autoimmune disease in which interstitial lung disease (ILD) is the leading cause of morbidity and mortality. Clinical management of the lung disease is mainly based ...
Two of the most commonly used classifications for the posterior malleolus fracture are Haraguchi and Bartoníček. Both classifications are based on the morphology of the fracture. This study makes an i...
39 patients with ankle fractures who met inclusion criteria were selected. All the fractures were analyzed and classified twice by each of the 20 observers using Bartoníček and Haraguchi's classificat...
Analysis was made by Kappa coefficient (ƙ). The global intraobserver value was ƙ = 0.627 in the Bartoníček classification and ƙ = 0.644 in the Haraguchi one. The first round global interobserver ƙ = 0...
Bartoníček and Haraguchi classifications of the posterior malleolus fracture have both substantial intraobserver agreement but moderate to substantial agreement in interobserver analysis....
IV....
BOLD delay is an emerging, noninvasive method for assessing cerebral perfusion that does not require the use of intravenous contrast agents and is thus particularly suited for longitudinal monitoring....
This study analyzes the effects of retrospective lipid suppression, a simulated macromolecular prior knowledge and different spline baseline stiffness values on 9.4T multi-slice proton FID-MRSI data s...
Measurements were performed twice on 5 volunteers using a short TR and TE FID MRSI 2D sequence at 9.4T. The effects of retrospective lipid L2-regularization, macromolecular spectrum and different LCMo...
Transversal, sagittal, and coronal slices of many metabolite ratio maps correspond to the anatomically expected concentration relations in gray and white matter for the majority of the cerebrum when u...
Reproducible concentration ratio maps (/tCr) for 4 metabolites (total choline, N-acetylaspartate, glutamate, and myoinositol) spanning the majority of the cerebrum and 6 metabolites (N-acetylaspartylg...
Many researchers try to understand a biological condition by identifying biomarkers. This is typically done using univariate hypothesis testing over a labeled dataset, declaring a feature to be a biom...
Nanoforms (NFs) of a substance may be distinguished from one another through differences in their physicochemical properties. When registering nanoforms of a substance for assessment under the EU REAC...
Immortalized or continuous cell lines are invaluable tools in basic and preclinical research. However, the widespread use of misidentified cell lines is a serious threat to scientific reproducibility....
Videogames are emerging as a promising experimental paradigm in neuroimaging. Acquiring gameplay in a scanner remains challenging due to the lack of a scanner-compatible videogame controller that prov...
Expression quantitative trait locus (eQTL) analysis associates SNPs with gene expression; these relationships can be represented as a bipartite network with association strength as "edge weights" betw...